Publication Name	World Journal of Gastroenterology
Manuscript ID	34887
Country	China

Received	2017-05-31 01:43
Peer-Review Started	2017-05-31 01:53
To Make the First Decision	2017-06-22 02:39
Return for Revision	2017-06-22 05:29
Revised	2017-07-03 05:12
Second Decision	2017-07-06 11:35
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2017-07-12 04:14
Articles in Press	2017-07-12 04:14
Publication Fee Transferred	2017-07-20 06:06
Edit the Manuscript by Language Editor	2017-07-27 10:13
Typeset the Manuscript	2017-08-18 07:13
Publish the Manuscript Online	2017-08-28 06:54

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Prospective Study
Article Title	Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection
Manuscript Source	Unsolicited Manuscript
All Author List	Yan Xue, Li-Xin Zhang, Lei Wang, Tao Li, Yun-Dong Qu and Feng Liu
ORCID	Author(s) ORCID Number Yan Xue http://orcid.org/0000-0001-6185-2424 Li-Xin Zhang http://orcid.org/0000-0001-9795-6487 Lei Wang http://orcid.org/0000-0002-8240-9795 Tao Li http://orcid.org/0000-0002-2548-5476 Yun-Dong Qu http://orcid.org/0000-0003-4119-4422 Feng Liu http://orcid.org/0000-0001-7060-3710
Funding Agency and Grant Number	Funding Agency Grant Number Project of Science and Technology Development Plan of Ji'nan city 201506004 Youth Fund of 2nd Hospital of Shandong University Y2014010014
Corresponding Author	Lei Wang, MD, PhD, Professor, Department of Infectious Diseases and Hepatology, the Second Hospital of Shandong University, 247 Beiyuan Road, Jinan 250033, Shandong Province, China. wlcrb@sdu.edu.cn
Key Words	Hepatitis C virus; Sofosbuvir; Daclatasvir; Kidney transplantation; Direct-acting antivirals
Core Tip	This is a prospective study to assess the efficacy and safety of sofosbuvir and daclatasvir regimens for kidney transplantation (KT) patients with hepatitis C virus (HCV) infection. This study enrolled a prospective cohort of consecutive Chinese KT patients with HCV infection. The recipients were given sofosbuvir combined with daclatasvir with or without ribavirin. Sofosbuvir and daclatasvir treatments are highly efficient and safe. Patients tolerated the regimens and no serious adverse events were observed. Larger prospective cohort studies are needed to validate these results.
Publish Date	2017-08-28 06:54
Citation	Xue Y, Zhang LX, Wang L, Li T, Qu YD, Liu F. Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection. World J Gastroenterol 2017; 23(32): 5969-5976
URL	http://www.wjgnet.com/1007-9327/full/v23/i32/5969.htm
DOI	http://dx.doi.org/10.3748/wjg.v23.i32.5969

Full Article (PDF)	WJG-23-5969.pdf
Full Article (Word)	WJG-23-5969.doc
Manuscript File	34887-Review.doc
Answering Reviewers	34887-Answering reviewers.pdf
Audio Core Tip	34887-Audio core tip.mp3
Biostatistics Review Certificate	34887-Biostatistics statement.pdf
Clinical Trial Registration Statement	34887-Clinical trial registration statement.pdf
Conflict-of-Interest Disclosure Form	34887-Conflict-of-interest statement.pdf
Copyright License Agreement	34887-Copyright assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	34887-Grant Application Form(s).pdf
Signed Informed Consent Form(s) or Document(s)	34887-Informed consent statement.pdf
Institutional Review Board Approval Form or Document	34887-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate	34887-Language certificate.pdf
Peer-review Report	34887-Peer-review(s).pdf
Scientific Misconduct Check	34887-Scientific misconduct check.pdf
Scientific Editor Work List	34887-Scientific editor work list.pdf